Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - Maintenance

NCT00781937 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

422

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolism and Nutrition Disorder
Obesity

Interventions

DRUG: liraglutide
DRUG: placebo

Sponsor

Novo Nordisk A/S